Hillary McKellar (Brennan)

Hillary McKellar (Brennan) has had a long and successful career in the pharmaceutical industry. Hillary began in 2001 at Cubist Pharmaceuticals as a Sr. Clinical Trials Manager and Program Manager for R&D. In 2007, they moved to Sunovion Pharmaceuticals Inc., where they served as an Associate Director, Clinical Project Manager, Principal Clinical Project Manager, and Sr. Clinical Project Manager. In 2016, they joined SAGE Therapeutics as the Director of Clinical Operations & Development. In 2020, they were promoted to Sr. Director, Head of Clinical Operations at Fulcrum Therapeutics. Most recently, in 2022, they became the Executive Director of Clinical Operations at Cardurion Pharmaceuticals.

Hillary McKellar (Brennan) obtained a Bachelor of Arts degree in Biology/Biological Sciences, General from Colby College. In 2021, they also obtained two certifications from LinkedIn: "How to Be Both Assertive and Likable" and "Leveraging Virtual and Hybrid Teams for Improved Effectiveness".